Censoring refers to a situation in survival analysis where the event of interest is not observed for some of the individuals under study.

In this Statistical Primer, we’ll define three types of censoring often seen in survival analysis studies.

Censoring occurs when the information on the survival time is incomplete or only partially observed.

Censoring can have a significant impact on the analysis and interpretation of survival data. It is essential to appropriately handle censoring in survival analysis to obtain accurate estimates of survival times, covariate effects, and other related parameters.

There are different types of censoring in survival analysis:

  • Right-censoring: This occurs when a participant is still alive or event-free at the end of the study period. In other words, the follow-up time for the participant ends before the event occurs. This is the most common type of censoring in survival analysis.
  • Left-censoring: This occurs when the true event time is known to be less than a certain time, but the exact time is unknown. For example, if an individual is diagnosed with a disease before the study begins but the date of onset of the disease is not known, we have left-censoring.
  • Interval-censoring: This occurs when the event time is known to fall within a certain interval, but the exact time of the event is unknown. For example, if a person develops glaucoma in between visits to the optician but the exact onset is unknown, we have interval censoring.

Latest Resources

Tutorials

multistate v4.4.0: semi-parametric multi-state modelling

The headlines: predictms now supports the Cox model as a transition model, estimated using merlin or stmerlin Predictions from a multi-state Cox model are implemented using a simulation approach Supported predictions from a multi-state Cox model include transition probabilities, probability, and length of stay, los Let’s take a look at what we can now do with multistate and in particular, the predictms command. We’ll […]
Read more

Specialist subjects

Clinical Trial Services

Clinical Trial Services Biostatistics services of RDA are the cornerstone of clinical trial design, execution, and interpretation. Biostatistical support by RDA will ensure that your clinical development programme and inherent studies are scientifically rigorous, appropriately powered, and capable of generating reliable evidence for regulatory approval and clinical use. RDA’s expertise for clinical development is focused […]
Read more

Statistical Primers

What is immortal time bias?

Immortal time bias Immortal time bias is a type of bias that can occur in observational research when the study design allows for a period of time during which the outcome of interest cannot occur, often referred to as “immortal time”. Simply put, immortal time bias occurs when information from a future event is incorporated into the […]
Read more

Specialist subjects

Real-World Evidence (RWE)

Real-World Evidence Real-world evidence (RWE) refers to data and information that, unlike data generated in clinical trials conducted in controlled environments, has been obtained from everyday clinical practice, patient registers, or other sources outside the clinical trial setting. RWE plays a crucial role in complementing traditional clinical trial data, providing insights into the safety, effectiveness, […]
Read more

Tutorials

An introduction to joint modelling of longitudinal and survival data

This post gives a gentle introduction to the joint longitudinal-survival model framework, and covers how to estimate them using our merlin command in Stata. A joint model consists of a continuous, repeatedly measured (longitudinal) outcome, and a time-to-event, with the two models linked by random effects, or functions of them. Let’s formally define everything we need. For […]
Read more

Tutorials

Joint longitudinal and competing risks models: Simulation, estimation and prediction

This post takes a look at an extension of the standard joint longitudinal-survival model, which is to incorporate competing risks. Let’s start by formally defining the model. We will assume a continuous longitudinal outcome, $$y_{i}(t) = m_{i}(t) \epsilon_{i}(t)$$ where $$m_{i}(t) = X_{1i}(t)\beta_{1} + Z_{i}(t)b_{i}$$ and \(\epsilon_{i}(t)\) is our normally distributed residual variability. We call \(m_{i}(t)\) our […]
Read more

Tutorials

A user-defined/custom hazard model

This tutorial will illustrate some of the more advanced capabilities of merlin when modelling survival data, but with the aim of using an accessible example. During my PhD, Paul Lambert and I developed stgenreg in Stata for modelling survival data with a general user-specified hazard function, with the generality achieved by using numerical integration to calculate the cumulative hazard […]
Read more

Tutorials

Joint longitudinal-survival models with time-dependent effects (non-proportional hazards)

In this post we’ll focus on how to model time-dependent effects (non-proportional hazards), specifically within a joint longitudinal-survival model. Now joint models are becoming commonplace in medical research, but as always, the fundamentals still matter, and indeed are often ignored. We’re going to look at how to account for time-dependency in both baseline covariates in […]
Read more

Tutorials

Relative survival analysis

Relative survival models are predominantly used in population based cancer epidemiology (Dickman et al. 2004), where interest lies in modelling and quantifying the excess mortality in a population with a particular disease, compared to a reference population, appropriately matched on things like age, gender and calendar time. One of the benefits of the approach is […]
Read more

Tutorials

Simulation, modelling and prediction with a non-linear covariate effect in survival analysis

Let’s begin. There will be a single continuous covariate, representing age, with a non-linear effect influencing survival. We’ll simulate survival times under a data-generating model that incorporates a non-linear effect of age. We’ll then fit some models accounting for the non-linear effect of age, and finally make predictions for specified values of age. Sounds simple, […]
Read more

Specialist subjects

Haematology

Haematological malignancies At Red Door Analytics, we have extensive experience in working with haematological malignancies, demonstrated through 18 publications in peer-reviewed journals. Our expertise spans epidemiological studies on prognosis and late effects, as well as randomised clinical trials. Based in Stockholm, we have unique experience in accessing and working with registry data from the Nordic […]
Read more

Statistical Primers

What is censoring?

Censoring refers to a situation in survival analysis where the event of interest is not observed for some of the individuals under study. In this Statistical Primer, we’ll define three types of censoring often seen in survival analysis studies. Censoring occurs when the information on the survival time is incomplete or only partially observed. Censoring […]
Read more
All Resources